ChronLAW.com News for attorneys, lawyers, and insurance, banking, credit, finance, government, education and law related professionals, covering politics, business, medicine, crime, law enforcement and other legal topics.
Oncology Pharma Signs License Agreement for mRNA Intellectual Property As It Reveals Strategic Plans for Treating Pancreatic Cancer – BioSpace
SAN FRANCISCO, CA / ACCESSWIRE / April 7, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) signed a license agreement with Regen BioPharma Inc. for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer. This license agreement expands the Company's portfolio of intellectual property that It plans to develop for niche biotechnology markets. Oncology Pharma issued a statement "We are looking to expand our presence in the cancer therapy market. This ...
